Global Peptic Ulcer Testing industry

Jun 16, 2010, 11:21 ET from Reportlinker

NEW YORK, June 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Peptic Ulcer Testing industry

http://www.reportlinker.com/p0197156/Global-Peptic-Ulcer-Testing-industry.html

This report analyzes the worldwide markets for Peptic Ulcer Testing in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 39 companies including many key and niche players such as Beckman Coulter, Inc., Biomerica, Inc., Kibion AB, Meretek Diagnostics Group of Otsuka America, Pharmaceutical, Inc., Meridian Bioscience, Inc., Orion Diagnostica Oy, and Quidel Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

PEPTIC ULCER TESTING MCP-3417

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. INTRODUCTION II-1

Peptic Ulcer Overview II-1

Global Prevalence of Peptic Ulcers II-1

Global Prevalence of H. Pylori II-2

Table 1: Prevalence of Helicobacter pylori Infection in

Select Countries (2008) (includes corresponding Graph/Chart) II-2

Developing Countries - A Breeding Ground for H. pylori II-3

The Importance of H. Pylori Testing II-3

Men At Higher Risk of Peptic Ulcers Than Women II-3

2. MARKET OVERVIEW II-4

A Peek into the Infectious Disease Tests Market II-4

Higher Prevalence of Infectious Diseases Fuels Demand for

Rapid Tests II-4

Current Market Estimates and Forecasts II-4

Availability of Tests - A Major Factor Affecting the Market II-5

Diagnostic Techniques in Developing Regions II-5

Rapid Tests - Accelerating Time to Diagnosis II-5

Cost Factors Favor Serological and Urease Testing II-6

Histology and Culture Tests, PCR - Though Pricey, Offer Value

Addition II-6

Invasive Tests Marred by Cost and Convenience Issues II-7

Table 2: Total Number of Biopsy Procedures in Select

Countries (2008) (includes corresponding Graph/Chart) II-7

Technological Changes Sweeping the Rapid Tests Landscape II-8

Differential Accuracy of Diagnostic Tests in Adults and Children II-8

Guidelines for Diagnosing H. Pylori Ulcers in Children II-8

Antibody Tests Not Recommended for Children; Biopsy Tests

More Pertinent II-9

3. PEPTIC ULCERS - THE DISEASE, CAUSES, SYMPTOMS, TYPES,

DIAGNOSIS, AND TREATMENT II-10

Peptic Ulcer - The Disease II-10

Discovery of Real Cause of Peptic Ulcers II-10

Causes of Peptic Ulcers II-10

Helicobacter Pylori (H. pylori) II-11

Non-steroidal Anti-inflammatory Drugs (NSAIDs) II-11

Others II-11

Causes of Peptic Ulcers in Children II-12

Symptoms of Peptic Ulcers II-12

Types of Peptic Ulcers II-12

Gastric Ulcers II-13

Duodenal Ulcers II-13

The Diagnosis II-13

Diagnosis of Ulcers II-13

Diagnosis of H. Pylori II-14

Treatment of Peptic Ulcers II-14

Drugs Prescribed in Peptic Ulcer Treatment II-15

4. PEPTIC ULCER DIAGNOSIS AND TESTS II-16

Diagnosis of Ulcers II-16

The Upper GI Contrast Studies / Barium X-rays II-16

Endoscopy II-16

Diagnosis of H. pylori II-16

A Comparison of Key Diagnosing Tests for H. pylori II-17

Tissue Tests II-17

Gastrointestinal Endoscopy: Gold Standard in Diagnoses of

Upper GI Diseases II-17

Rapid Urease Tests II-17

Histology Tests II-18

Culture Tests II-18

Blood Tests or Serological Tests II-18

Laboratory-based Tests II-19

ELISA Tests II-19

Point-of-Care Tests II-19

Urea Breath Test - The Most Effective Diagnoses for H. Pylori

Detection II-19

Types of Urea Breath Tests II-20

Carbon-14-Urea Breath Test (PYtest) II-20

Precautionary Measures to be taken Prior to Performance

of UBT II-20

Federal Legislation Governing the 14C UBT II-20

Carbon-13-Urea Breath Test II-20

Breath Tests Vs. Other Diagnostic Assays II-21

Stool Tests II-21

Select H. pylori Diagnostic Tests/Test Kits in the Market II-21

Select H. pylori Blood Tests II-22

Heliprobe™ Systems II-23

FlexSure. HP II-23

QuickVue H. pylori gII test II-24

CLOtest Rapid Urease Test II-24

EZ-H.P. (Bulk) and EZ-H.P. (Professional) II-24

The One-Step H. Pylori Test II-25

Mk 5 Automated Breath 13C Analyzer (ABCA) II-25

BreathTek™ UBT Test II-25

5. RECENT INDUSTRY ACTIVITY II-26

Beckman Coulter Inks Licensing Deal with NUI Galway for

Molecular Tests II-26

Meretek Diagnostics and Otsuka America Announce Merger II-26

Meretek Strikes Deal with PAML II-26

Sanko Junyaku Introduces New Diagnostic Kit for H. pylori

Infection II-27

Kibion AB Acquires Noster System II-27

Meridian Obtains CLIA Waiver Status for ImmunoCard STAT!® Test

from FDA II-27

Meridian Bags FDA Clearance for Stomach Ulcer Test II-27

6. HISTORIC DEVELOPMENTS II-28

Oridion Wins FDA Clearance for BreathID® H. Pylori Breath Test II-28

MedMira Obtains FDA Approval to Market Rapid Peptic Ulcer Test II-28

Enteric Products Wins FDA Clearance for PP-CAP® IgA EIA II-28

Quidel Corporation Unveils Latest Version of H. pylori Test II-28

Trinity Biotech Secures FDA Clearance for Uni-Gold™ Test II-29

Biomerica Launches Pepgen Test II-29

7. FOCUS ON SELECT GLOBAL PLAYERS II-30

Beckman Coulter, Inc. (USA) II-30

Biomerica, Inc. (USA) II-30

Kibion AB (Sweden) II-31

Meretek Diagnostics Group of Otsuka America Pharmaceutical,

Inc. (USA) II-32

Meridian Bioscience, Inc. (USA) II-32

Orion Diagnostica Oy (Finland) II-33

Quidel Corporation (USA) II-34

8. GLOBAL MARKET PERSPECTIVE II-35

Table 3: World Recent Past, Current & Future Analysis

forPeptic Ulcer Testing (Rapid Tests for H. Pylori) by

Geographic Region - USA, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) II-35

Table 4: World Historic Review for Peptic Ulcer Testing (Rapid

Tests for H. Pylori) by Geographic Region - USA, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) II-36

Table 5: World 15-Year Perspective for Peptic Ulcer Testing

(Rapid Tests for H. Pylori) by Geographic Region - Percentage

Breakdown of Dollar Revenue for USA, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets for Years 2003, 2009, & 2015 (includes

corresponding Graph/Chart) II-37

III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Current and Future Analysis III-1

Peptic Ulcers Prevalence III-1

Peptic Ulcers Guidelines III-2

The Need for Peptic Ulcers Testing Education III-2

Medicare Raises Reimbursement for UBT 13C Test in Georgia III-3

Strategic Corporate Developments III-3

Historic Developments III-4

Select Major Players III-6

B.Market Analytics III-10

Table 6: US Recent Past, Current & Future Analysis for

Peptic Ulcer Testing (Rapid Tests for H. Pylori) with Annual

Revenue Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) III-10

Table 7: US Historic Review for Peptic Ulcer Testing (Rapid

Tests for H. Pylori) with Annual Revenue Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) III-10

Table 8: US Recent Past, Current & Future Analysis for

Peptic Ulcer Testing (Rapid Tests for H. Pylori) with Annual

Sales Figures in Thousand Units for Years 2007 through 2015

(includes corresponding Graph/Chart) III-11

Table 9: US Historic Review for Peptic Ulcer Testing (Rapid

Tests for H. Pylori) with Annual Sales Figures in Thousand

Units for Years 2001 through 2006 (includes corresponding

Graph/Chart) III-11

2. JAPAN III-12

A.Market Analysis III-12

Current and Future Analysis III-12

Product Launch III-12

B.Market Analytics III-13

Table 10: Japanese Recent Past, Current & Future Analysis

for Peptic Ulcer Testing (Rapid Tests for H. Pylori) with

Annual Revenue Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) III-13

Table 11: Japanese Historic Review for Peptic Ulcer Testing

(Rapid Tests for H. Pylori) with Annual Revenue Figures in

US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) III-13

3. EUROPE III-14

A.Market Analysis III-14

Current and Future Analysis III-14

Historic Developments III-14

Key Players III-14

B.Market Analytics III-16

Table 12: European Recent Past, Current & Future Analysis

for Peptic Ulcer Testing (Rapid Tests for H. Pylori) Annual

Revenue Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) III-16

Table 13: European Historic Review for Peptic Ulcer Testing

(Rapid Tests for H. Pylori) with Annual Revenue Figures in

US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) III-17

4. ASIA-PACIFIC III-18

A.Market Analysis III-18

Current and Future Analysis III-18

B.Market Analytics III-18

Table 14: Asia-Pacific Recent Past, Current & Future

Analysis for Peptic Ulcer Testing (Rapid Tests for H.

Pylori) with Annual Revenue Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) III-18

Table 15: Asia-Pacific Historic Review for Peptic Ulcer

Testing (Rapid Tests for H. Pylori) with Annual Revenue

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) III-19

5. LATIN AMERICA III-20

A.Market Analysis III-20

Current and Future Analysis III-20

B.Market Analytics III-20

Table 16: Latin America Recent Past, Current & Future

Analysis for Peptic Ulcer Testing (Rapid Tests for H.

Pylori) with Annual Revenue Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) III-20

Table 17: Latin America Historic Review for Peptic Ulcer

Testing (Rapid Tests for H. Pylori) with Annual Revenue

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) III-21

6. REST OF WORLD III-22

A.Market Analysis III-22

Current and Future Analysis III-22

Canada - Prevalence of Peptic Ulcers III-22

B.Market Analytics III-23

Table 18: Rest of World Recent Past, Current & Future

Analysis for Peptic Ulcer Testing (Rapid Tests for H.

Pylori) with Annual Revenue Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) III-23

Table 19: Rest of World Historic Review for Peptic Ulcer

Testing (Rapid Tests for H. Pylori) with Annual Revenue

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) III-23

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 39 (including Divisions/Subsidiaries - 42)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 22

Canada 1

Japan 3

Europe 12

Germany 1

The United Kingdom 1

Rest of Europe 10

Asia-Pacific (Excluding Japan) 4

------------------------------------------

To order this report:

Diagnostics Industry: Global Peptic Ulcer Testing industry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

CONTACT:  

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com